SD
Therapeutic Areas
Sera Prognostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PreTRM® Test | Risk assessment for spontaneous preterm birth in asymptomatic singleton pregnancies | Commercial |
| LikeMine™ Platform | Digital health platform for pregnancy insights and outcome comparisons | Development |
Leadership Team at Sera Prognostics
GC
Gregory C. Davis
President and Chief Executive Officer
JM
Jay Moyes
Chief Financial Officer
AP
Andrew P. Cossrow
Executive Vice President, Strategy and Corporate Development
MS
M. Steven Binder
Chief Business Officer
KR
Kristen R. Hadeed
Vice President, Marketing
ER
Elaine R. Mardis
Board Member